<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287363/" ref="ordinalpos=2744&amp;ncbi_uid=4576972&amp;link_uid=PMC3287363" image-link="/pmc/articles/PMC3287363/figure/F7/" class="imagepopup">Fig. 7. From: Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF <span class="highlight" style="background-color:">signaling</span> in developing rat hippocampus. </a></div><br /><div class="p4l_captionBody">A working model of ID/anemia-suppressed hippocampal IGF signaling. Hippocampal ID-lowered IGF/PI3K/Akt signaling (downward light gray arrows) preferentially leads to reduced neurogenesis and synaptogenesis. In contrast, PI3K-independent activation of the Erk1/2 pathway (upward black arrows) may overcome its PI3K-dependent repression. In an adaptive sense, this may have a stimulatory effect on promoting cellular survival. mTOR, mammalian target of rapamycin; FoxO1, forkhead box O1; Hif1α, hypoxia-inducible factor 1α.</div></div>